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Background: Smokeless tobacco is of increasing interest to public health researchers and policy makers. This study
aims to measure prevalence of smokeless tobacco use (nasal dry snuff, snus and chewing tobacco) among young
Swiss men, and to describe its correlates. Methods: We invited 13 245 young men to participate in this survey on
socio-economic and substance use data. Response rate was 45.2%. We included 5720 participants. Descriptive
statistics and multivariable-adjusted logistic regression were performed. Results: Mean age of participants was
19.5 years. Self-reported use once a month or more often was 8% for nasal dry snuff, 3% for snus and negligible
for chewing tobacco. In multivariable-adjusted logistic regression, the odds for nasal dry snuff use increased in non
daily smokers [odds ratio (OR) 2.41, 95% confidence interval (CI) 1.90–3.05], compared with non smokers, partici-
pants reporting risky weekly drinking volume (OR 3.93, 95% CI 1.86–8.32), compared with abstinents, and binge
drinking once a month or more often (OR 7.41, 95% CI 4.11–13.38), compared with never binge drinking. Nasal dry
snuff use was positively associated with higher BMI, average or above family income and German language,
compared with French, and negatively associated with academic higher education, compared with non higher
education, and occasional cannabis use, compared with no cannabis use. Correlates of snuswere similar to those of
nasal dry snuff. Conclusion: One in 12 young Swiss men use nasal dry snuff and 3% use snus. Consumption of
smokeless tobacco is associated with a cluster of other risky behaviours, especially binge drinking.
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Introduction
Smokeless tobacco refers to a variety of products made of tobaccothat are not consumed by combustion. Types of smokeless
tobacco include oral wet snuff, such as snus used in Sweden and
other Scandinavian countries, or, for example, chewing tobacco
known as dip in the United States. Nasal dry snuff, historically the
most prevalent form of smokeless tobacco in continental Europe and
United Kingdom, is another form of smokeless tobacco.1 Dry snuff
is a flavoured tobacco powder that is inhaled through the nose. Only
few studies examined the health impact of smokeless tobacco. One
recent study suggested increased odds of newly diagnosed type 2
diabetes mellitus in middle-aged male heavy snus users in
Sweden.2 Snus use has also been associated with increased risk of
preterm delivery and preeclampsia in Swedish women.3 Bolinder
et al.4 found a higher risk for cardiovascular mortality in
smokeless tobacco users compared with non users. A more recent
meta-analysis of eight Swedish cohort studies found a modestly
increased case fatality among snus users with acute myocardial
infarction, compared with non snus users with acute myocardial
infarction.5 However, the findings of this study did not support
any relationship between the use of snus and the development of
acute myocardial infarction.5 Although the association between
smokeless tobacco and the risk of cancer, such as cancer of the
mouth, seems to be inconsistent throughout the literature,6,7 one
study suggests that smokeless tobacco use is associated with an
increased risk of pancreatic cancer.7
Smokeless tobacco has a high addictive potential and is an
increasing concern to health care professionals, public health
researchers and policy makers. Tobacco companies use new
marketing strategies to promote smokeless tobacco as an
alternative to smoking because of smoke free regulations.8–10
Prevalence of smokeless tobacco is known to be highest in young
male populations. A survey of 5471 male US college students aged
18 to 24 years found a prevalence of 8.7% for current use and
13.9% for past year use.11 In Sweden, 29% of the male population
aged 16–29 used snus in 2012.12 Chewing tobacco initiation has
been associated with smoking- and alcohol-related problems in the
United States,13 and prevalence of binge drinking is elevated
among young Swedish males who use snus.14 Selling of snus is
restricted in the European Union and in Switzerland but not in
Sweden.15,16 However, the importation of snus for personal use is
allowed in Switzerland, and it can be ordered online, without
effective age control. According to the Swiss customs, the
quantity of oral tobacco imported from Sweden was multiplied
by 56 between 2004 and 2011 from 282 to 27 410 metric tons.17
This selling restriction does not touch other forms of smokeless
tobacco. In Switzerland, prevalence of smokeless tobacco use
between 2008 and 2010 was estimated to be 2.3% in the general
population (both men and women aged 14 to 65 years old). Nasal
dry snuff was used by 7.8% of men aged 14 to 19 years, but only
0.2% of them indicated using snus and 0.4% using chewing
tobacco.18 To our knowledge, the characteristics of nasal dry
snuff users have not been studied previously, and it is not clear
whether findings concerning other types of smokeless tobacco can
be directly applied to nasal dry snuff.
The aims of this study were to describe the prevalence of nasal dry
snuff use and other forms of smokeless tobacco among young men
in Switzerland, and to assess its association with the use of other
substances such as cigarettes, alcohol and cannabis, and with socio-
economic factors.
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Methods
Study design
All young men presenting to three out of six Swiss army recruitment
centres in Lausanne, Windisch and Mels between 23 August 2010
and 15 November 2011 were invited to participate in a survey. In
Switzerland, conscription is mandatory, and almost all men have to
present to a recruitment centre after their 18th birthday, where their
aptitude for military or civil service is assessed. To account for
regional differences, two of the chosen recruitment centres were
situated in the German-speaking part of Switzerland and one in
the French-speaking part. The study protocol was approved by the
Ethics Committee for Clinical Research of the Lausanne University
Medical School (Protocol No. 15/07). A few days after written
consent and enrolment at these recruitment centres, participants
were invited by email to complete an anonymous online question-
naire containing questions about their socio-economic background,
and their consumption of alcohol, tobacco, cannabis and other
drugs (questionnaire available online: www.c-surf.ch). The question-
naire, in German or French, was used according to the language
spoken by participants in each region and was available in paper
form on request. To increase response rate, reminders were sent
twice by email to participants who consented but failed to fill out
the questionnaire, and encouraging telephone interviews were
performed if email reminders failed. Participants who completed
the questionnaire were rewarded with a voucher of a value of 30
Swiss Francs. Data were collected until January 2012.
Participants
A total of 13 245 men were invited to participate in this study. Of
these, 7563 accepted to participate and signed the informed consent
form (consent rate: 57.1%), and 5987 filled out the questionnaire
(response rate: 45.2%). To test for potential non-consent or non-
response bias, a very short questionnaire on demographics, alcohol,
cannabis and tobacco consumption was handed out to all of the
6384 invitees in Lausanne and 6180 in Windisch and filled out by
6099 (95.5%) and 5720 (92.5 %) of them (overall 94.0% response
rate), respectively. Compared with non responders and non
consenters, a lower proportion of alcohol abstainers, heavy
drinkers, daily smokers, and heavy cannabis users, and a higher
proportion of non smokers and non cannabis users were found
among responders.19 We excluded 267 (4.5%) participants with
incomplete data for the main variables of interest. Compared with
included participants, these were slightly older (19.8 vs. 19.5 years,
P = 0.001), had a lower proportion of below average self-estimated
socio-economic status (38% vs. 44%, P = 0.04), a higher proportion
of French speakers than German speakers (67% vs. 54%, P < 0.001),
a higher proportion of low education level (72% vs. 57%, P = 0.001),
but a similar proportion of smokeless tobacco users (27.8% vs.
26.7%, P = 0.7).
Measurements
The questionnaire assessed self-reported smokeless tobacco use,
cigarette smoking, alcohol and cannabis use over the past 12
months. Participants who used one or more of these substances
were further questioned on the frequency and quantity of use. We
measured the prevalence of participants having used nasal dry snuff,
snus or chewing tobacco using three different definitions based on
frequency of smokeless tobacco use: at least once during the past 12
months, more than once a month and daily use. Smokers were
categorized into daily smokers, defined as at least one cigarette
every day, and non daily smokers, at least one cigarette in the past
12 months, but not every day. Participants who indicated alcohol
consumption answered an open-ended question on the number of
units of alcohol they drink in average per occasion, i.e. during a
normal day on which they consumed alcohol, as well as questions
on the number of drinking days per week and the frequency of binge
drinking, defined as drinking six or more units of alcohol on an
occasion. Pictures of drinks containing one unit of alcohol (10 g of
pure ethanol) were shown indicating the volume of each container,
e.g. 100 ml of wine or 250 ml of beer. To obtain the weekly drinking
volume, we multiplied the number of drinks per drinking day by the
number of drinking days. We categorized alcohol use into a high risk
group, 21 or more units of alcohol per week, and a moderate to low
risk group, less than 21 units per week, using a compromise between
the 14 drinks limit for brief interventions recommended by the
National Institute on Alcohol Abuse and Alcoholism,20 and the
28 drinks definition for harmful use of the World Health
Organization.21 We categorized participants according to the
frequency of binge drinking into three categories—frequent binge
drinkers (once a month or more often), occasional binge drinkers
(less than once a month) and never binge drinkers. We categorized
cannabis use as frequent if consumed twice a week or more and
occasional if consumed less than twice a week. These definitions
have been used in a previous report.22 Body mass index (BMI)
was calculated based on reported weight and height. No direct meas-
urements were made. Participants were categorized as underweight
(BMI <18.5 kg/m2), normal weight (BMI 18.5–24.9 kg/m2),
overweight (BMI 25–29.9 kg/m2) and obese (BMI 30 kg/m2),
according to the definition by the World Health Organization.23
As an indicator of socio-economic status, participants were asked
whether they estimated the income of their family above average, on
average or below average, according to the 2011 questionnaire of the
European School Survey on Alcohol and Other Drugs.24 In addition,
participants were questioned on their current education level and
were categorized, according to the International Standard
Classification of Education (ISCED),25 into a higher education
track, defined as participant in training for or in possession of a
diploma that gives access to academic—i.e. a universities or
federal institutes of technology, corresponding to ISCED level 5B
and C—or professional higher education—i.e. universities of
applied science and professional colleges, corresponding to ISCED
level 4 and 5A—and a non higher education track. Based on our
literature review, we selected socio-economic variables and other
factors known to be associated to smokeless tobacco use for our
analysis.
Data analysis
We built two multivariable-adjusted logistic regression models, one
using nasal dry snuff use once a month or more often and the other
one using snus use once a month or more often as dependent
variables, and variables suspected to be associated with smokeless
tobacco use based on previous knowledge as independent variables.
The test for linear trend in the BMI categories was calculated by
modelling the BMI ordinal category as a continuous variable. We
considered P < 0.05 as statistically significant for all statistical
analyses and used STATA software (version 12.1, Stata Corp.,
College Station, Texas).
Results
Sample characteristics
Characteristics of participants are shown in Table 1. Mean age of
participants was 19.5 years [standard deviation (SD) 1.26] ranging
from 17 to 31; 55% were French speaking, 45% German speaking,
44% estimated their family income below average and 43% were in a
higher education track. There were 21% of daily smokers and 26% of
non daily smokers; 6% drank >21 units of alcohol on average per
week; 46% drank 6 units of alcohol on at least one occasion per
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month; 10% used cannabis twice a week or more; and 21% used
cannabis less than twice a week.
Prevalence of smokeless tobacco use
Table 2 shows the prevalence of smokeless tobacco use. Self-reported
use of nasal dry snuff at least once in the past 12 months was 24%,
whereas consumption of snus at least once in the past 12 months was
reported by only 9% of participants. Eight percent of participants
reported using nasal dry snuff once a month or more often during
the past 12 months, and 3% used snus once a month or more often.
Only 0.5% and 1% of participants reported daily use of nasal dry
snuff and snus, respectively. Use of chewing tobacco was negligible.
Multivariable-adjusted logistic regressions
The results of the multivariable-adjusted logistic regressions are
shown in table 3. Non daily cigarette smokers had two times
increased odds of nasal dry snuff use compared with non smokers
[odds ratio (OR) 2.41, 95% confidence interval (CI) 1.90–3.05], but
no association was found with daily smoking. Participants drinking
1–20 units of alcohol per week had two times increased odds
(OR 2.12, 95% CI 1.06–4.23), and participants drinking >20 units
of alcohol per week had almost four times increased odds of nasal
dry snuff use (OR 3.93, 95% CI 1.86–8.32) compared with those
who did not drink alcohol. The odds of nasal dry snuff use in par-
ticipants reporting binge drinking less than once a month were three
times higher (OR 3.03, 95% CI 1.66–5.54), and seven times higher in
those with binge drinking once a month or more often (OR 7.41,
Table 3 Factors associated with smokeless tobacco use in
multivariable-adjusted logistical regression (N=5720)a
Variable Nasal dry snuffb
(n=482)
Swedish type oral
snusb (n=182)
OR (95% CI) OR (95% CI)
Age (per 1 more year) 0.79 (0.71–0.81) 0.88 (0.76–1.02)
BMI
<18.5 kg/m2 0.99 (0.52–1.87) (omitted)
18.5–24.9 kg/m2 (reference) 1 1
25–29.9 kg/m2 1.37 (1.07– 1.75) 1.28 (0.88–1.86)
>30 kg/m2 1.56 (0.99–2.47) 1.40 (0.94–12.39)
Language
French (reference) 1 1
German 2.01 (1.62–2.49) 1.72 (1.24–2.39)
Family income
Below average (reference) 1 1
Average or above 1.38 (1.12–1.69) 0.90 (0.66–1.23)
Education
Non higher education track
(reference)
1 1
Professional higher education
track
0.84 (0.63–1.13) 0.84 (0.53–1.31)
Academic higher education
track
0.60 (0.46–0.77) 0.58 (0.39–0.87)
Cigarette smoking
Non smoker (reference) 1 1
Non daily smoker 2.41 (1.90–3.05) 1.82 (1.26–2.62)
Daily smoker 1.20 (0.89–1.61) 1.04 (0.66–1.63)
Weekly alcohol volume
None (reference) 1 1
<21 units 2.12 (1.06–4.23) 0.80 (0.36–1.76)
21 units 3.93 (1.86–8.32) 1.36 (0.56–3.33)
Binge drinkingc
Never (reference) 1 1
Less than once a month 3.03 (1.66–5.54) 2.42 (1.02–5.77)
Once a month or more often 7.41 (4.11–13.38) 6.76 (2.91–15.75)
Cannabis use
No use (reference) 1 1
Less than twice a week 0.92 (0.73–1.17) 1.02 (0.71–1.47)
Twice a week or more 0.38 (0.25–0.58) 0.75 (0.43–1.31)
a: Adjusted for age, BMI, language, income, education track,
cigarette smoking, weekly alcohol volume, frequency and
cannabis use.
b: Once a month or more often in the past 12 months.
c: Defined as drinking six or more units of alcohol on an occasion.
Table 1 Characteristics of participants (N=5720)
Age
mean, SD 19.5 1.26
BMI
<18.5 kg/m2 (n, %) 186 3%
18.5–24.99 kg/m2 (n, %) 4351 76%
25– 29.99 kg/m2 (n, %) 959 17%
30kg/m2 (n, %) 224 4%
Language
German (n, %) 2591 45%
French (n, %) 3129 55%
Family income
Below average (n, %) 2536 44%
Average or above (n, %) 3184 56%
Education
Non higher education track (n, %) 3275 57%
Academic higher education track (n, %) 1558 27%
Professional higher education track (n, %) 887 16%
Cigarette smoking
Non smoker (n, %) 3028 53%
Non daily smoker (n, %) 1491 26%
Daily smoker (n, %) 1201 21%
Number of cigarettes per day (n=2692)
Mean, SD 8.2 7.43
Average weekly alcohol volume
None (n, %) 713 13%
<21 units of alcohol (n, %) 4650 81%
21 units of alcohol (n, %) 357 6%
Frequency of binge drinkinga
Never (n, %) 1188 21%
Less than once a month (n, %) 1887 33%
Once a month or more often (n, %) 2645 46%
Cannabis use
No (n, %) 3969 69%
Less than twice a week (n, %) 1207 21%
Twice a week or more (n, %) 544 10%
a: Defined as drinking six or more units of alcohol on an occasion.
Table 2 Smokeless tobacco use (N=5720)
Smokeless tobacco use, at least once in the past 12 months
None (n, %) 4191 73%
Yes, any (n, %) 1529 27%
-Dry snuff (n, %) 1347 24%
-Snus (n, %) 527 9%
-Chewing tobacco (n, %) 26 0.5%
Smokeless tobacco use, more than once a month during the past 12 months
None (n, %) 5216 90%
Yes, any (n, %) 594 10%
-Dry snuff (n, %) 482 8%
-Snus (n, %) 182 3%
-Chewing tobacco (n, %) 9 0.2%
Smokeless tobacco use, daily
None (n, %) 5636 98.5%
Yes, any (n, %) 84 1.5%
-Dry snuff (n, %) 29 0.5%
-Snus (n, %) 58 1%
-Chewing tobacco (n, %) 1 0.02%
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95% CI 4.11–13.38), compared with those never binge drinking.
Cannabis use twice a week or more was negatively associated with
smokeless tobacco use (OR 0.38, 95% CI 0.25–0.58), whereas no
association was found with cannabis use less than twice a week.
The odds of nasal dry snuff use once a month or more often
decreased by 21% with each increase in one year of age (OR 0.79,
95% CI 0.71–0.81 per one more year of age). Compared with par-
ticipants with normal weight, overweight participants had 37%
increased odds for nasal dry snuff use (OR 1.37, 95% CI
1.07–1.75). The point estimate increased throughout the BMI
categories, and there was a significant trend (P = 0.002), suggesting
that the odds for nasal dry snuff use increased linearly with BMI,
although results were not significant for obese and underweight par-
ticipants. Nasal dry snuff use was also associated to German
language (OR 2.01, 1.62–2.49) and average or above self estimated
family income (OR 1.38, 95% CI 1.12–1.69). Participants in the
academic tertiary education track had 40% decreased odds for
nasal dry snuff use (OR 0.60, 95% CI 0.46–0.77).
The multivariable-adjusted logistic regression using snus use once
a month or more often as dependent variable showed similar results
(table 3). However, the associations with BMI, family income,
education and cannabis use were not significant, probably because
of loss of power due to a lower prevalence of snus use. Nevertheless,
P for trend throughout the BMI categories was significant (P = 0.02).
Discussion
We found a high prevalence of nasal dry snuff use among young
Swiss men. One in four (24%) used nasal dry snuff at least once in
the past 12 months and one-third of them (8%) used nasal dry snuff
more than once a month. In comparison, 9% used snus at least once
in the past 12 months, one-third (3%) of them more than once a
month. Daily use of any form of smokeless tobacco was rare, and the
use of chewing tobacco negligible. In a telephone survey performed
in the Swiss population in 2010, the prevalence of nasal dry snuff use
was estimated at 7.8% among young men aged 14 to 19 years old,
but only 0.2% of them indicated using snus and 0.4% using chewing
tobacco.18 We found similar prevalence rates for nasal dry snuff and
chewing tobacco, but higher prevalence of snus in our survey. This
might be due to the slightly older age distribution in our sample.
Also, participants might have been more reluctant to report snus use
in a telephone survey. A non negligible proportion of young Swiss
men use snus despite of the restrictions. This may be due to new
marketing strategies of the tobacco industry.8 Also, sports such as ice
hockey might be a vector of snus use, as previously hypothesized.26
About one in two participants reported smoking, and one in five
(21%) daily smoking. This rate of daily smoking is comparable with
that found in the Swiss Survey of Tobacco Consumption (23%).18
However, we found a much higher rate of non daily smoking
compared with this survey (26% vs. 13%), probably because we
chose a less restrictive definition—at least one cigarette in the past
12 months. Almost half of the participants reported at least monthly
binge drinking (46%). Gmel et al. (2010)22 found a comparable
prevalence of binge drinking (58%) in a similar population of
3537 young men enrolled at the Swiss army recruitment centre
(mean age 19.9 years; SD 0.025).
We found a strong association between dry snuff use and binge
drinking. The association was especially strong in young men
reporting binge drinking on at least one occasion per month who
had more than seven times higher odds of use of nasal dry snuff
compared with young men who did not report binge drinking in the
past 12 months, after adjustment with potential confounders. Nasal
dry snuff use was also associated with non daily smoking, and weekly
alcohol volume, but it was not associated with daily smoking and
occasional cannabis use, and negatively associated with cannabis use.
Age, BMI, average or above self-estimated family income, and lower
education level were other correlates of nasal dry snuff use. We
found similar results for snus use.
The association with lower age is consistent with previous reports
on Swedish snus and smokeless tobacco in the US.13,27 Smokeless
tobacco use has also been associated with at risk alcohol consump-
tion and smoking. In a prospective cohort study among US military,
Hermes et al.13 found three to four times increased odds for
smokeless tobacco use initiation among smokers, and 21%
increased odds among participants with alcohol-related problems.
In a survey on 43 093 individuals in the US in 2001–2002, Agrawal
et al.28 found 5.4 times increased odds for smokeless tobacco use
among participant with alcohol abuse or dependence, and 10.8 times
increased odds for concomitant smokeless tobacco use and smoking.
The same study found an association of concomitant smokeless
tobacco use and smoking, and lifetime cannabis use (OR 2.12,
95% CI 1.76–2.55), but not of smokeless tobacco use alone, after
adjustment for age, sex, race, origin and alcohol and nicotine
dependence. In contrast to our results, smokeless tobacco use was
negatively associated with self-reported poverty, whereas concomi-
tant smokeless tobacco use and smoking was negatively associated
with college education. On the other hand, a cross-sectional survey
in Sweden showed that the current use of snus was positively
associated with mid-level and basic education, lower income and
rural place of residence in men.27 Hamari et al.29 found lower
rates of snus use among high school graduates, in a population of
male military recruits (mean age 19.4 years). Among 16–20–year-old
male Norwegians, however, no association between socio-educa-
tional status and snus use was found.30 In our study, we found an
association of dry snuff use with lower education level, and, surpris-
ingly, higher family income. We might hypothesize that smokeless
tobacco (despite its affordability) is more used among young people
with higher socio-economic status because it is a rather newer form
of tobacco. As for smoking, people of higher SES adopt this new
comportment first. The differences in the results of these three
studies might also be explained by the different age distribution
[40, 50 and 60 years for the Swedish study27; mean age of 46.4
years (SD 18.2) for the US study28; and 19.5 years (SD 1.27) in
the current survey] and different racial distribution, diverse in the
US study28; not surveyed but presumably rather uniformly
Caucasian in the Swedish study27 and in the current survey. In
addition, the variables education and income are not directly
comparable, as both studies measured completed education and
individual income, whereas we measured ongoing education and
family income. With regards to the Finnish29 and the Norwegian30
study, although educational systems may not be directly comparable,
the classification of education level as well as the study populations
seem to be rather similar to ours. Both studies did not test for family
income. The results of one previous study associating smokeless
tobacco use with overweight and weight gain is consistent with
our finding.31 To our knowledge, no study has ever assessed
regional differences of smokeless tobacco use in Switzerland.
Our study has some limitations. First, the cross-sectional design
does not allow for drawing causal conclusions. Associations might be
due to confounding with other variables which were not included in
the analysis. Second, smokeless tobacco use and consumption of
other psychoactive drugs such as cigarettes, cannabis and alcohol
were self-reported and there was no validation. This might have
conducted to underestimation of the real prevalence as participants
tend to underreport their consumption.32 Also, substance use might
be underestimated by non-response bias. Therefore, the reported
prevalence rates should be interpreted with caution. Third, our
sample is restricted to men and our results are therefore not
applicable to women. Furthermore, the study excludes Swiss
residents with foreign nationality. The sample was drawn at three
out of six recruitment centres only: one in the French-speaking part,
draining all of the French-speaking cantons, but two out of four
centres in the German-speaking part, draining 14 out of 19
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German-speaking cantons, and none in the Italian-speaking part of
the country. Therefore, the sample is not representative with regards
to language, even though we feel comfortable to claim that the
sample of each recruitment centre is representative of the young
male population in the area that it drains. Family income, as a
proxy of parents’ socio-economic status, was estimated by the par-
ticipants themselves and might not be comparable with measures of
socio-economic status in other studies. Because participants were
too young to have completed higher education, we considered in-
dividuals training for a diploma allowing later access to higher
education. This proxy of higher education might not be
comparable with variables of higher education in other studies, as
persons in the non higher education track may still switch to a
higher education track later on, and has to be interpreted with
caution. We did not adjust our results for rural origin of the par-
ticipants, which has been found to be associated to smokeless
tobacco use in Sweden.27
In conclusion, nasal dry snuff is used once a month or more often
by about one in 12 young Swiss men. About one in 11 young Swiss
men have tried snus, a form of smokeless tobacco previously unknown
in Switzerland and 3% use it on a monthly basis, despite of restric-
tions. Daily use of smokeless tobacco is rare. Use of nasal dry snuff is
associated with risky alcohol consumption and non daily smoking.
This association is strongest in young men with frequent binge
drinking, pointing to a cluster of substance use risk behaviour in
this population of young men. Nasal dry snuff has been largely
neglected by researchers and policy makers, and its potential health
hazards, including its role in inducing nicotine dependence, should be
assessed in longitudinal studies. Snus is a form of smokeless tobacco
newly present in Switzerland, and snus users seem to have a similar
profile as nasal dry snuff users with regards to the use of cigarettes,
alcohol and cannabis, and socio-economic factors.
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Key points
 About one in 12 young Swiss men use nasal dry snuff, the
traditional type of smokeless tobacco in this country.
 About 3% of young Swiss men use snus, a type of smokeless
tobacco imported from Sweden.
 Nasal dry snuff and snus are associated with a cluster of risk
behaviours, including binge drinking.
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Background: To reduce the possibility of cigarette appearance misleading consumers about harm caused by the
product, the European Commission’s draft Tobacco Products Directive proposed banning cigarettes <7.5mm in
diameter. It appears however, following a plenary vote in the European Parliament, that this will not be part of
the final Tobacco Products Directive. To reduce the appeal of cigarettes, the Australian Government banned the
use of branding on cigarettes and stipulated a maximum cigarette length as part of the Tobacco Plain Packaging
Act. We explored the role, if any, of cigarette appearance on perceptions of appeal and harm among adolescents.
Methods: Focus group research with 15-year-olds (N=48) was conducted in Glasgow (Scotland) to explore young
people’s perceptions of eight cigarettes differing in length, diameter, colour and decorative design. Results: Slim
and superslim cigarettes with white filter tips and decorative features were viewed most favourably and rated
most attractive across gender and socio-economic groups. The slimmer diameters of these cigarettes
communicated weaker tasting and less harmful looking cigarettes. This was closely linked to appeal as thinness
implied a more pleasant and palatable smoke for young smokers. A long brown cigarette was viewed as particu-
larly unattractive and communicated a stronger and more harmful product. Conclusion: This exploratory study
provides some support that standardising cigarette appearance could reduce the appeal of cigarettes in adoles-
cents and reduce the opportunity for stick design to mislead young smokers in terms of harm.
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Introduction
The guidelines on Article 13 of the Framework Convention onTobacco Control recommend that ‘individual cigarettes or
other tobacco products should carry no advertising or promotion,
including design features that make products attractive’.1 To reduce
the appeal of cigarettes, the Australian Government stipulated partial
product standardisation as part of the Tobacco Plain Packaging Act,
which was fully implemented in December 2012. The use of
branding (including colour, brand name and decorative elements)
on cigarettes is now prohibited, a maximum length for cigarettes has
been specified and cigarettes must be white or white with an
imitation cork filter. The legislation does not, however, place any
parameters on cigarette diameter.2
The European Commission proposed a different approach from
Australia with the draft Tobacco Products Directive (TPD)
announced in December 2012. The draft TPD did not propose a
ban on branding on cigarettes but instead a ban on cigarettes less
than 7.5 mm in diameter, on the basis that ‘cigarettes with a
diameter of less than 7.5 mm shall be deemed misleading’.3 This
recommendation would have prohibited the sale of very slim
cigarettes, called ‘superslims’, in the European Union. However,
no research to date has examined the impact of slimmer cigarettes
on product attributes such as the perceived attractiveness or level of
harm among adolescents.
Tobacco companies increasingly offer brand variants that feature
alternative cigarette diameters, decorative designs and lengths.4,5
Analyses of tobacco industry documents show that modifications
to the appearance of cigarettes can make them more appealing to
specific target groups, notably ‘starter’ and female smokers and can
help to boost sales and market share.6–8 Exemplifying the potential
for product design to influence growth, sales of slim cigarettes grew
by 50% from 23 855 million sticks in 2000 to 35 673 million sticks in
2010 in Europe, despite a general decline in factory manufactured
cigarette sales.9 This is consistent with global trends where the
superslims segment is reported to have grown 10 times faster than
the overall market in the past 5 years.10
It has been suggested that younger people are often the target of
novel product design11 and most vulnerable to the impact of tobacco
marketing as they are especially susceptible to tobacco brand
imagery and particularly concerned with their identity.12,13
Recently, the public health focus on cues which influence brand
imagery and product beliefs has lain with cigarette packaging.14–17
However, marketing literature suggests that cigarette characteristics,
such as length, diameter, colour and decorative elements, are
intrinsic product cues that are not only consumed along with the
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